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Mosquito-borne viruses, like dengue and 
chikungunya, can change rapidly, reducing 
the accuracy of current diagnostic tests.  
AMD helps scientists monitor changes in 
virus genomes, which improves our ability to 
predict future outbreaks.  
Mosquitoes can leave more than an irritating itch when they bite, 
they also can infect people with viruses, such as dengue and 
chikungunya. For decades, dengue has been found in tropical and 
sub-tropical regions of the world. Annually, an estimated 390 million 
people are infected with dengue. While chikungunya wasn’t 
detected in the Western Hemisphere until 2013, the epidemic has 
already spread to 45 countries in the region with reports of 1.5 million 
sick people.  
Both dengue and chikungunya are spread by two species of Aedes 
mosquitoes: Aedes aegypti and Aedes albopictus. These mosquitoes 
are found throughout the Western Hemisphere, including parts of the 
United States. Mosquitoes become infected after biting a person sick 
with the virus. Once infected, the mosquito can bite other people 
and spread the virus. 
Chikungunya and dengue cause similar symptoms, including high 
fever and body aches. Dengue symptoms can be so severe, in fact, 
that its nickname is “breakbone fever” because of the painful, 
sometimes debilitating joint pain it causes. Chikungunya means “that 
which bends up” in the Makonde language of eastern Africa and  
CDC’s AMD Initiative 
Using AMD to track changes in dengue and chikungunya 
viruses  
AMD Project: Taking the Bite Out of Mosquito-
borne Viruses 
September 2015 
can cause intense, sometimes prolonged joint pain. Public health officials need clinicians to order diagnostic 
testing so that preventive measures, such as mosquito control, can be precisely focused. 
 
However, diagnostic tests can’t always keep up with changes in viruses. Dengue and chikungunya have RNA 
genomes that can change rapidly, which can reduce the accuracy of diagnostic tests. For example, a 2010 
dengue outbreak in Micronesia nearly went unrecognized because the virus had changed and the existing test 
could no longer detect it. Fortunately, CDC and collaborating institutes around the world used advanced 
molecular detection (AMD) to sequence the RNA genomes of thousands of existing dengue virus strains 
collected over the previous 20 years. With this information, CDC developed a new diagnostic test more able to 
detect all current strains of dengue virus in most patients. The new test is used globally for accurate diagnosis—a 
much more difficult and lengthy task without AMD. 
 
Using AMD, CDC scientists can monitor changes in virus genomes, which improves understanding of transmission 
and ability to predict future outbreaks. Through this work, scientists will be able to develop highly specific 
diagnostic tests for some emerging viruses that would otherwise be confused with known viruses. This is the case 
with Zika, which has recently been reported for the first time in the Western Hemisphere and can be confused 
with dengue. By routinely monitoring pathogens with AMD, scientists will be able to more quickly and accurately 
diagnose the sick and better respond to epidemics.  
For more information on dengue and chikungunya, visit the CDC websites at www.cdc.gov/Dengue and 
www.cdc.gov/chikungunya. 
www.cdc.gov/amd 
